After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Pinpointing who will and won’t get Alzheimer’s disease is tricky for doctors, but new research suggests it may soon get ...

Measuring insulin resistance with a simple, low-cost blood test can help predict the pace of cognitive decline in patients ...

Dr. Nicholas Milano of Medical University of SC says medications such as Lecanemab and donanemab give Alzheimer's patients ...

In the case of the amyloid drugs, Eisai Biogen's Leqembi (lecanemab) and Eli Lilly's Kisunla (donanemab) – there are also ...

What exactly is Alzheimer’s disease, and how common is it? A: Alzheimer’s disease is a neurodegenerative disease that causes dementia. It is caused in part by the accumulation of abnormally folded ...

The experts agreed that carnosic acid could potentially improve the inflammation that generally occurs in most aging brains. There are cautions however.

According to the Alzheimer’s Association, more than 120,000 Missourians are living with the disease. But a newly approved ...

A simple blood test could reveal which early Alzheimer’s patients are most at risk for rapid decline. Researchers found that ...